Fibroblast-derived Spondin-2 promotes dysplastic transition in metaplastic gastric epithelial cells
Listen to this summary
The authors investigate the role of fibroblast-derived factors in the transition from metaplasia to dysplasia in gastric epithelial cells, identifying Spondin-2 (SPON2) as a key mediator of this process. Through various techniques, including single-cell RNA sequencing and spatial transcriptomics, they demonstrate that SPON2 promotes dysplastic changes in metaplastic gastroids, highlighting its potential as a significant factor in early gastric carcinogenesis. Ultimately, the study positions SPON2 as the first identified fibroblast-derived factor that drives pre-neoplastic progression in gastric epithelium.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Gastroenterology
View all →Sep 17, 2026 · Gastroenterology
Faecalibacterium prausnitzii EXL01 Strain for the prevention of multiple-recurrent Clostridioides difficile Infection
Sep 9, 2026 · Gastroenterology
Short-Term Success, Long-Term Failure: Strain Turnover and Virulence Re-Emergence May Drive Relapse in Pouchitis
Sep 3, 2026 · Gastroenterology
Impact of Family History on Colorectal Cancer Risk in Inflammatory Bowel Disease and in Matched General Population Comparators
Sep 1, 2026 · Gastroenterology
Individualized targeted exclusion diet based on confocal laser endomicroscopy does not improve irritable bowel syndrome symptoms: a randomized controlled crossover trial
Aug 31, 2026 · Gastroenterology
Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls
Aug 27, 2026 · Gastroenterology
The CA19-9 glycan is a viable target for CAR T cell therapy in pancreatic and other solid tumors
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


